Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1988 Mar;85(6):2019-23.
doi: 10.1073/pnas.85.6.2019.

Comparison of ion channels in multidrug-resistant and -sensitive human leukemic cells

Affiliations
Comparative Study

Comparison of ion channels in multidrug-resistant and -sensitive human leukemic cells

S C Lee et al. Proc Natl Acad Sci U S A. 1988 Mar.

Abstract

Tumor cell lines selected to grow in the presence of one "natural product" antineoplastic drug often develop cross-resistance to others. This multidrug resistance (MDR) is believed to be a major problem in cancer therapy. Organic Ca2+-channel blockers, such as verapamil, can reverse this resistance and render MDR cells in culture nearly as sensitive to the antineoplastic drugs as the drug-sensitive cells from which they were derived. It has therefore been suggested that Ca2+ channels may play a role in MDR. To determine directly whether there are electrophysiological correlates of MDR, we used whole-cell and single-channel patch-clamp techniques to survey the ion channels in a drug-sensitive human T-cell leukemia line, CCRF-CEM, and a MDR variant, CEM/VLB100. We found no evidence for a voltage-gated Ca2+ channel. However, we did identify three other current/channel types: a voltage-gated tetrodotoxin-sensitive inward current carried by Na+, a voltage-gated labile outward current carried by K+, and a nonselective cation channel reversing at 0 mV. Drug-sensitive and -resistant cells were the same with respect to the level of expression of these channels.

PubMed Disclaimer

References

    1. Cell. 1986 Nov 7;47(3):371-80 - PubMed
    1. Cancer Res. 1986 Feb;46(2):778-84 - PubMed
    1. Cancer Res. 1985 Jul;45(7):3220-4 - PubMed
    1. J Cell Physiol. 1985 Oct;125(1):72-81 - PubMed
    1. Biochem Pharmacol. 1987 Sep 15;36(18):2879-87 - PubMed

Publication types